Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Helus Pharma Appoints Michael Halstead As Chief Executive Officer

PRIVATEAug 03, 2026•6 days ago

Position

Chief Executive Officer

Company

Helus Pharma

Michael Halstead
TorontoManufacturingBiotechnologyHealth CarePharmaceutical

Description

Helus Pharma announces the appointment of Michael Halstead as Chief Executive Officer, effective immediately. Mr. Halstead will leverage his extensive leadership experience to advance the company's upcoming clinical and commercial milestones.

Company Information

Company

Helus Pharma

Location

Toronto, Ontario, Canada

About

Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options. The company is advancing patient-centered innovation through clinical excellence to deliver meaningful and durable outcomes that support long-term healing.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Helus Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.